May 22, 2020

Trump’s Hydroxychloroquine Cocktail Connected to 45 Percent Increased Risk of Death

“What do you have to lose?” the president recently asked.

Yuri Gripas/ZUMA

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

“What do you have to lose?” President Donald Trump asked reporters last week while, once again, promoting the controversial drug hydroxychloroquine as a potential coronavirus treatment. 

It turns out, as experts have repeatedly warned, a whole lot.

A new Lancet study released on Friday and first reported by the Washington Post revealed that taking hydroxychloroquine to combat COVID-19 was connected to a significantly increased chance of death. The study, which examined 96,032 patients and is the largest to investigate the antimalarial drug’s potential in fighting the virus, had even more alarming news for taking hydroxychloroquine with an antibiotic, the combination once touted by Trump as a “gamechanger” in the fight against coronavirus. “For those receiving hydroxychloroquine and an antibiotic—the cocktail endorsed by Trump—there was a 45 percent increased risk of death and a 411 percent increased risk of serious heart arrhythmias,” the Post reported. The study doesn’t necessarily extend to those taking hydroxychloroquine as a preventive measure, as Trump claimed this week to be doing.

The astounding findings come on the heels of a study published last month that reported more deaths among US veterans treated with hydroxychloroquine than those who received standard care. Trump initially claimed that he hadn’t seen the veterans’ study—a curious assertion considering his aggressive campaign to promote the drug—but then on Tuesday accused the medical researchers of political motivation. “That was a false study done,” he said at a White House event. “It was given by obviously not friends of the administration.”

The president has not yet offered a conspiratorial angle with which to discredit the Lancet study, but something tells me that’s inevitable.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate